Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Intranasal microemulsion based brain delivery system of rivastigmine: formulation and ex-vivo characterization

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Poster
  • By: SHAH BRIJESH, Maheshkumar (B.V. Patel Pharmaceutical Education & Research Development (PERD) Centre, Pharmaceutical Technology, Ahmedabad, India)
  • Co-author(s): Misra, Manju (National Institute of Pharmaceutical Education and Research, Ahmedabad, India)
    Padh, Harish (Sardar Patel University, Anand, India)
  • Abstract:

    Alzheimer's disease is a progressive neurodegenerative disorder leading to irreversible loss of neurons, cognition and formation of abnormal protein aggregates. Rivastigmine, a reversible cholinesterase inhibitor used for the treatment of Alzheimer's disease, undergoes extensive first-pass metabolism, thus limiting its absolute bioavailability to..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses